Genetic Analysis of Keloids
Part of paid clinical trials in Farmington, Connecticut.
- Sponsor
- UConn Health
- Study ID
- NCT01619553
- Status
- Recruiting
Conditions
- Keloid
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Key Dates
- Start date
- Apr 30, 2009
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 7,000 participants (estimated)
Arms
- Arm: affectedindividuals with keloids
- Arm: unaffectedunrelated unaffected controls or unaffected family members
Primary Outcome Measure
Identification of genetic elements [ Time Frame: at time of identification ]
Central Contacts
- Ernst Reichenberger, PhD866-512-9897
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Connecticut Health Center (UCHC) | Farmington | Connecticut | 06030-3705 | - |
Find similar trials in Farmington, CT
By research site
Related Studies
- Preoperative Silicone Ointment and Wound HealingEnrolling By Invitation · Yale University · New Haven, Connecticut
- Web Based Investigation of Natural History of Keloid Disorder, an Online SurveyRecruiting · Tirgan, Michael H., M.D. · New York, New York
- Radiotherapy for KeloidsRecruiting · Montefiore Medical Center · The Bronx, New York
- Ritlecitinib in Patients With Keloids or Those Undergoing KeloidectomyPHASE2 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York